Treatment of orbital metastases from a primary midgut neuroendocrine tumor with peptide-receptor radiolabeled therapy using 177 lutetium-DOTATATE

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical oncology 2013-06, Vol.31 (17), p.e272-e275
Hauptverfasser:	Dobson, Rebecca, Vinjamuri, Sobhan, Hsuan, James, Banks, Melissa, Terlizzo, Monica, Wieshmann, Hulya, Daousi, Christina, Poston, Graeme P, Cuthbertson, Daniel J
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Humans Lutetium - administration & dosage Male Neuroendocrine Tumors - pathology Neuroendocrine Tumors - radiotherapy Octreotide - administration & dosage Octreotide - analogs & derivatives Orbital Neoplasms - radiotherapy Orbital Neoplasms - secondary Organometallic Compounds - administration & dosage Radioisotopes - administration & dosage Radiopharmaceuticals - administration & dosage
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!